Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05196932 · ClinicalTrials.gov registry record
COVID Card Pilot Study to Detect Antibodies to SARS-CoV-2
A clinical trial, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- 56
- Enrollment target
NCT05196932 is a clinical trial that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 56 participants.
The verdict
NCT05196932 has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- 56 participants
- Enrollment target
Study Summary
This study aims to investigate the clinical performance characteristics of the novel point-of-care, semi-quantitative test for SARS-CoV-2 in the Emergency Department compared to the gold standard (ELISA).
Interventions
- DEVICE Novel point-of-care, semi-quantitative test for SARS-CoV-2 antibodies
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2022-08-31 |
| Est. Completion | 2023-04-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05196932
The ClinicalTrials.gov registry entry for NCT05196932 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Novel point-of-care, semi-quantitative test for SARS-CoV-2 antibodies is the first listed.
NCT05196932 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05196932 about?
NCT05196932 is a clinical study titled "COVID Card Pilot Study to Detect Antibodies to SARS-CoV-2". This study aims to investigate the clinical performance characteristics of the novel point-of-care, semi-quantitative test for SARS-CoV-2 in the Emergency Department compared to the gold standard (ELISA).
What is the current status of trial NCT05196932?
This trial is currently completed. The enrollment target is 56 participants. The study started on 2022-08-31. Estimated completion is 2023-04-21.
What interventions are being tested in trial NCT05196932?
The interventions under investigation include: Novel point-of-care, semi-quantitative test for SARS-CoV-2 antibodies (DEVICE).
Who is sponsoring clinical trial NCT05196932?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.